Find the Adequate Dose of Nalbuphine for Laparoscopic Cholecystectomy

• Status: Unknown status
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluate the adequate dose of mutonpain for laparoscopic cholecystectomy in the management of post operative pain. The investigators will randomize patients into three groups to compare the analgesia effects and side effects.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
• Treatments: Nalbuphine

Criteria

Inclusion Criteria:

• patient accept laparoscopic cholecystectomy

• age:20-80 years old

Exclusion Criteria:

• nalbuphine allergy

• chronic pain

• active liver disease that would affect metabolization of nalbuphine

• patient who had regular pain medications

• patient who could not cooperate to the evaluation of the survey

• dementia or other psychiatric disease